Medicure (MCUJF) EBITDA Margin (2009 - 2026)
Medicure (MCUJF) recorded quarterly EBITDA Margin of 3.08% in Q1 2026, up 102.28% quarter-over-quarter from 135.5% in Q4 2025, and up 1619.0% on a YoY basis from 0.18% in Q1 2025.
Medicure (MCUJF) EBITDA Margin (2009 - 2026) Analysis & Trends
Medicure's EBITDA Margin history runs 18 years deep, the most recent figure standing at 3.08% for Q1 2026.
- In Q1 2026, EBITDA Margin rose 1619.0% year-over-year to 3.08%; the TTM figure through Mar 2026 stood at 44.94% (down 4179.0% YoY), while the FY2025 annual figure was 27.74%, down 3087.0% from the prior year.
- EBITDA Margin was 3.08% for Q1 2026 at Medicure, up from 135.5% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 85.73% in Q4 2022 to a low of 135.5% in Q4 2025.
- Historically, EBITDA Margin has averaged 3.51% across 5 years, with a median of 3.08% in 2026.
- The sharpest annual moves came in 2022 and 2025: EBITDA Margin soared 5576 bps in 2022, then sank 14619 bps in 2025.
- A 5-year view of EBITDA Margin shows it stood at 85.73% in 2022, then plunged by 138 bps to 32.4% in 2023, then surged by 133 bps to 10.69% in 2024, then sank by 1368 bps to 135.5% in 2025, then jumped by 102 bps to 3.08% in 2026.
- The last three EBITDA Margin figures came in at 3.08% (Q1 2026), 135.5% (Q4 2025), and 12.67% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 16.37% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 36.83% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 41.69% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -1.01% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 22.74% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 22.39% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -170.35% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -16.25% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 21.55% |
| 10 | Medicure | - | - | 2.57 Mn | 3.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.08% |
| Dec 31, 2025 | -135.50% |
| Sep 30, 2025 | -12.67% |
| Jun 30, 2025 | -27.26% |
| Mar 31, 2025 | -13.11% |
| Dec 31, 2024 | 10.69% |
| Sep 30, 2024 | 7.74% |
| Jun 30, 2024 | -19.46% |
| Mar 31, 2024 | 9.66% |
| Dec 31, 2023 | -32.40% |
| Sep 30, 2023 | 10.78% |
| Jun 30, 2023 | -3.50% |
| Mar 31, 2023 | 4.71% |
| Dec 31, 2022 | 85.73% |
| Sep 30, 2022 | 44.83% |
| Jun 30, 2022 | 1.61% |
| Mar 31, 2022 | 5.48% |
| Sep 30, 2021 | -10.94% |
| Jun 30, 2021 | 14.53% |
| Mar 31, 2021 | -26.01% |